4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000899243-18-004667
Franchise Lead, Neurology sold 18,750 shares at $50.00 ($937,500)
- Franchise Lead, Neurology acquired 18,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Panzara Michael A. · Franchise Lead, Neurology
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-02-15 | Exercise or conversion : show line 1 in the form | +18,750 | $21.69 | $406,688 | 58,486 | D |
| 2018-02-15 | Sale : show line 2 in the form | −18,750 | $50.00 | $937,500 | 39,736 | D |
| Open-market sales · 18,750 sh · avg $50.00 · $937,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-02-15 | Exercise or conversion : show line 3 in the form Share Option (right to buy) | −18,750 | $21.69 | 2026-07-11 | 18,750 | 131,250 | D |
Loading xslF345X03/doc4.xml…